New hope for transplant patients: drug combo targets rare lymphoma
Disease control
Recruiting now
This study tests whether combining two drugs, tafasitamab and rituximab, can shrink or eliminate a type of lymphoma that sometimes occurs after an organ transplant. The trial enrolls 28 adults who have this condition and have not yet received treatment. The goal is to see how man…
Phase: PHASE2 • Sponsor: Timothy Voorhees • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC